remifentanil has been researched along with Pantothenate Kinase-Associated Neurodegeneration in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carrero, E; Fàbregas, N; Hurtado, P; Rumia, J; Salvador, L | 1 |
1 other study(ies) available for remifentanil and Pantothenate Kinase-Associated Neurodegeneration
Article | Year |
---|---|
[Anesthesia considerations for deep-brain stimulation in a patient with type-2 pantothenate kinase deficiency (Hallervorden-Spatz disease)].
Topics: Adult; Androstanols; Anesthesia, Intravenous; Deep Brain Stimulation; Dystonic Disorders; Female; Globus Pallidus; Humans; Intubation, Intratracheal; Muscle Rigidity; Neuromuscular Nondepolarizing Agents; Pantothenate Kinase-Associated Neurodegeneration; Phosphotransferases (Alcohol Group Acceptor); Piperidines; Preanesthetic Medication; Propofol; Radiography, Interventional; Remifentanil; Rocuronium | 2009 |